Yonghong Biotechnology is expected to log in to Xingkuai on the 24th. From the left in the picture are the chairman of Yonghong Li Fangyu, the general manager Zhong Weikai, and Zhong Weikai's wife Liu Xiangci (photographed by reporter Chen Yongji)

[Reporter Chen Yongji/Taipei Report] Yongxin Investment Holdings (3705)'s animal pharmaceutical factory Yonghong Biotechnology (6936) is expected to enter the market on the 24th of this month. A press conference was held yesterday. The focus of the meeting was not only on the company's operating conditions In addition, another "juicy" point is on Mrs. Zhong Weikai, the general manager of Yonghong--"the most beautiful Master Chief" Liu Xiangci.

Yongxin Pharmaceutical acquired a foreign pharmaceutical factory in 2016 and merged the original animal business division independently to form Yonghong Biotechnology, which has since become the largest animal pharmaceutical factory in Taiwan.

Zhong Weikai said that Yonghong’s self-consolidated revenue last year was 1.185 billion yuan, its after-tax net profit was 107 million yuan, and its EPS was 1.69 yuan.

Among them, therapeutic drugs and feed additives containing drugs accounted for 60% of the revenue, and feed additives and pet health products without drugs accounted for 40%. In addition, the domestic sales accounted for about 83%, and the export sales accounted for 17%. The proportion of export sales is expected to increase this year. to more than 20%.

Please read on...

Zhong Weikai pointed out that at present, Yonghong's revenue from economic animals (pigs, chickens, etc.) accounts for nearly 98%, and pets only account for 2%. Since the revenue ratio of economic animals and pet products of large international animal pharmaceutical companies is 6:4 Therefore, I hope that the revenue of Yonghong's pets will also increase to 40% in the future, and the target will exceed 10% within 5 years. During this period, the revenue of economic animals will continue to grow.

Zhong Weikai said that the current Taiwan animal health care market is 60 billion yuan, of which economic animals account for a relatively small proportion of about 12 billion yuan, and pets are nearly 50 billion yuan, and the pet market grows at an annual rate of 8-10%, while economic animals only account for 3-4% , so Yonghong has a considerable room for growth.

However, Yonghong was affected by the sharp rise in the price of raw materials such as soybeans and wheat last year. Although the revenue increased slightly, the profit decreased slightly. However, Zhong Weikai believes that the raw materials have gradually stabilized in the second half of last year. With the drug certificate, growth can be expected, and the overall operation is expected to return to the growth track this year.

Grasp the pulse of the economy with one hand I subscribe to Free Finance Youtube channel

Already added friends, thank you

Welcome to 【Free Finance】

feel good

Already liked it, thank you.